United States-based STI Pharma LLC announced yesterday that it has named Frank Mullery as its new president and CCO.

Mullery has more than 15 years of experience in the pharmaceutical industry, most recently serving as the president, Institutional Business at Mylan Inc, from 2016 to 2019. Prior to this, Mullery was CFO of North America for Mylan and has held roles of increasing scope and complexity in both the commercial and financial functions for Teva Pharmaceuticals and Viropharma Inc.

In his new role at STI Pharma, he will report directly to Anup Dam, chairman and manager of STI Pharma.